Document Detail

Earlier Diagnosis of Progressive Disease during Bevacizumab Treatment Using O-(2-18F-Fluorethyl)-L-tyrosine Positron Emission Tomography in Comparison with Magnetic Resonance Imaging.
MedLine Citation:
PMID:  23759368     Owner:  NLM     Status:  In-Data-Review    
AbstractAntiangiogenic treatment using bevacizumab in brain tumor patients may cause difficulties in the diagnosis of tumor progression (ie, nonenhancing tumor progression). Newly defined criteria for treatment assessment and diagnosis of tumor progression (ie, RANO [Response Assessment in Neuro-Oncology] criteria) have implemented signal alterations on T2/fluid-attenuated inversion recovery (FLAIR) sequences to changes in contrast enhancement. However, T2/FLAIR hyperintensity may be influenced by other causes (eg, radiation-induced leukoencephalopathy, peritumoral edema, gliosis). Positron emission tomography using the radiolabeled amino acid O-(2-[18F]fluoroethyl)-l-tyrosine (18F-FET-PET) may help detect the metabolically active tumor extent. We present 18F-FET-PET imaging findings in a glioblastoma patient during bevacizumab treatment suggesting an earlier diagnosis of tumor progression than magnetic resonance imaging changes, which are based on the RANO criteria.
Norbert Galldiks; Marion Rapp; Gabriele Stoffels; Veronika Dunkl; Michael Sabel; Karl-Josef Langen
Related Documents :
24434638 - The effect of radiation on the immune response to cancers.
10482448 - Synthesis and properties of some novel anti-calmodulin drugs.
12523818 - Gex1 compounds, novel antitumor antibiotics related to herboxidiene, produced by strept...
12423648 - Influence of vitamin d3 metabolites on cell proliferation and cytotoxicity of adriamyci...
19336518 - Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tum...
19470728 - Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultane...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular imaging     Volume:  12     ISSN:  1536-0121     ISO Abbreviation:  Mol Imaging     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-06-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101120118     Medline TA:  Mol Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  273-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Incidence of Chlamydia trachomatis infection in women in England: two methods of estimation.
Next Document:  Impact of Anesthetics On 3'-[18F]Fluoro-3'-Deoxythymidine ([18F]FLT) Uptake in Animal Models of Canc...